Nausea and vomiting
Information
- Disease name
- Nausea and vomiting
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06045364 | Active, not recruiting | Phase 1/Phase 2 | Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation | October 1, 2023 | August 1, 2024 |
| NCT00003685 | Completed | Phase 3 | Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer | August 1, 1997 | February 10, 2009 |
| NCT00003817 | Completed | Phase 2 | Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy | October 1999 | July 2001 |
| NCT00003213 | Completed | Phase 3 | Drugs to Reduce the Side Effects of Chemotherapy | May 1996 | August 1999 |
| NCT00004895 | Completed | Phase 2 | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | October 1999 | October 2002 |
| NCT00005994 | Completed | N/A | Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy | August 2000 | July 2001 |
| NCT00006348 | Completed | Phase 3 | Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment | October 2000 | September 2001 |
| NCT00020657 | Completed | Phase 3 | Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer | July 2001 | October 2004 |
| NCT00064272 | Completed | Phase 2 | UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer | May 2003 | |
| NCT00169572 | Completed | Phase 2 | Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy | February 2005 | |
| NCT00179348 | Completed | N/A | Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer | February 8, 2001 | July 20, 2016 |
| NCT00293384 | Completed | N/A | Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant | October 2004 | February 2012 |
| NCT00310063 | Completed | N/A | Acupressure in Preventing Nausea and Vomiting in Young Cancer Patients Receiving Chemotherapy | April 2005 | May 2007 |
| NCT00343460 | Completed | Phase 3 | APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer | June 2006 | February 2009 |
| NCT00343863 | Completed | N/A | Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer | January 2006 | December 2010 |
| NCT00381862 | Completed | Phase 2 | Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX | June 2006 | July 2008 |
| NCT00416689 | Completed | Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer | April 2000 | January 2006 | |
| NCT01590147 | Completed | N/A | Supportive Intervention Programs Study | June 2011 | July 2013 |
| NCT01553578 | Completed | N/A | Healing Touch or Guided Imagery In Treating Pain, Fatigue, Nausea, and Anxiety in Patients Undergoing Chemotherapy | February 2012 | February 2013 |
| NCT00590317 | Completed | Phase 2 | Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department | March 2005 | September 2008 |
| NCT00719173 | Completed | Phase 1 | Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer | August 2005 | October 2010 |
| NCT00748267 | Completed | N/A | Hypnosis in Reducing Pain and Other Side Effects in Women Undergoing Surgery for Breast Cancer | August 2008 | December 2010 |
| NCT00880191 | Completed | Phase 3 | Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy | April 2009 | May 2015 |
| NCT05533281 | Completed | Phase 4 | Efficacy of Three Antiemetics in Preventing Nausea and Vomiting | September 15, 2022 | November 3, 2023 |
| NCT04560114 | Completed | Phase 2 | Effect of Inhaled Aromatherapy on Chemo-Induced Nausea Vomiting (NCVI): CINVAROM (Chemotherapy Induced Nausea Vomiting and AROMatherapy) | December 14, 2020 | June 30, 2023 |
| NCT03185156 | Completed | Phase 4 | The Preventive Effects of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate | June 28, 2017 | January 30, 2018 |
| NCT00902733 | Completed | N/A | Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer | July 2008 | February 2010 |
| NCT02116530 | Completed | Phase 3 | Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy | August 2014 | November 2015 |
| NCT02026778 | Completed | N/A | Comparison of the Effect of Ondansetron and Combined Ondansetron and Betahistine on Postoperative Nausea and Vomiting After Gynecological Laparoscopy | December 2013 | November 11, 2014 |
| NCT01718132 | Completed | Reduction of Postoperative Pain, Nausea and Vomiting | January 2009 | June 2012 | |
| NCT00978185 | Completed | Phase 3 | Acupressure Wristbands or Standard Care in Controlling Nausea Caused by Chemotherapy | November 2008 | October 2010 |
| NCT00978549 | Completed | Phase 3 | Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer | April 2008 | October 2010 |
| NCT05837156 | Enrolling by invitation | Phase 1 | A Clinical Study to Evaluate Cyclopofol Injection for the Prevention of Postoperative Nausea and Vomiting | August 2, 2023 | December 30, 2023 |
| NCT06415084 | Not yet recruiting | Prevalence of Hyperemesis Gravidarum | July 2024 | April 2026 | |
| NCT06382012 | Not yet recruiting | Phase 2/Phase 3 | Antiemetic Fosaprepitant To Remedy Nausea and Vomiting | June 2024 | December 2024 |
| NCT06282211 | Recruiting | Phase 3 | the Efficacy and Safety of Ondansetron Oral Soluble Pellicles | February 20, 2024 | December 29, 2024 |
| NCT06200168 | Recruiting | Phase 3 | Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer | December 20, 2023 | December 31, 2026 |
| NCT01696734 | Recruiting | Phase 3 | Domperidone in Treating Patients With Gastrointestinal Disorders | October 23, 2012 | October 31, 2025 |
| NCT06314906 | Recruiting | Phase 3 | Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer | March 7, 2024 | March 31, 2027 |
| NCT05690802 | Recruiting | N/A | The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV | May 16, 2022 | May 30, 2029 |
| NCT01275664 | Terminated | N/A | Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer | June 2011 | |
| NCT02550119 | Terminated | N/A | Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy | April 19, 2006 | April 1, 2010 |
| NCT00900068 | Terminated | Blood Samples From Patients on a Clinical Trial to CINV During HSCT | August 2008 | October 2009 | |
| NCT00418678 | Terminated | Phase 4 | A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting | August 2006 | December 2007 |
| NCT00895245 | Terminated | Phase 2 | Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy | February 2009 | February 2011 |
| NCT00930332 | Terminated | Phase 1 | Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain | June 17, 2010 | January 6, 2012 |
| NCT00903396 | Terminated | Phase 2 | Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | September 2009 | May 2013 |
| NCT01372787 | Unknown status | Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer | April 12, 2011 | ||
| NCT01669213 | Unknown status | N/A | Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension | August 2012 | August 2013 |
| NCT05016180 | Unknown status | Phase 2 | Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery | September 25, 2020 | December 25, 2021 |
| NCT00004219 | Unknown status | Phase 3 | Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma | ||
| NCT00891761 | Withdrawn | Phase 3 | A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy | September 2009 | July 2010 |
| NCT00903305 | Withdrawn | N/A | Nurse-Provided Care or Standard Care in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | July 2008 | April 2009 |
| NCT00499668 | Withdrawn | N/A | Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer | August 2007 | March 2008 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002017
- ICD10 preferred id (Insert disease from ICD10)
- D0014983
- ICD10 class code (Insert disease from ICD10)
- R11